Walleye Trading
CBIO

Walleye Trading’s Crescent Biopharma CBIO Stock Holding History

Walleye Trading’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-189
Closed -$71K – 4535
2020
Q2 		$71K Sell
189
-376
-67% -$106K ﹤0.01% 3673
2020
Q1 		$129K Buy
+565
New +$216K 0.01% 2943
2019
Q4 		– Sell
-300
Closed -$129K – 4549
2019
Q3 		$129K Buy
+300
New +$193K 0.01% 3207
2016
Q3 		– Sell
-47
Closed -$34K – 5214
2016
Q2 		$34K Buy
47
+46
+4,600% +$31.7K ﹤0.01% 4240
2016
Q1 		$1K Buy
+1
New +$513 ﹤0.01% 5183

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return